Virbac SA (VIRB.PA)
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|51||2006||Chairwoman of the Supervisory Board|
|63||1999||Chairman of the Management Board|
|79||2006||Vice Chairwoman of the Supervisory Board|
|Chief Financial Officer, Member of the Management Board|
|57||Executive Vice President Corporate Development, General Manager, Member of the Management Board|
- French and Benelux stocks-Factors to watch on April 13
- BRIEF-Virbac Q1 Revenue Up At 193.5 Million Euros
- French and Benelux stocks-Factors to watch on March 15
- Animal medicines group Virbac sees slow sales growth this year
- BRIEF-Virbac FY Net Profit From Ordinary Activities Down 16.3 Pct At 29.5 Million Euros